2.15
price up icon4.13%   0.09
after-market 시간 외 거래: 2.16 0.01 +0.47%
loading
전일 마감가:
$2.06
열려 있는:
$2.04
하루 거래량:
18,656
Relative Volume:
1.03
시가총액:
$20.96M
수익:
-
순이익/손실:
$-17.93M
주가수익비율:
-0.9389
EPS:
-2.29
순현금흐름:
$-14.28M
1주 성능:
-2.50%
1개월 성능:
+2.14%
6개월 성능:
+12.89%
1년 성능:
+31.60%
1일 변동 폭
Value
$2.0011
$2.20
1주일 범위
Value
$1.99
$2.45
52주 변동 폭
Value
$1.325
$3.10

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name
명칭
Cocrystal Pharma Inc
Name
전화
(786) 459-1831
Name
주소
19805 N. CREEK PARKWAY, BOTHELL, WA
Name
직원
12
Name
트위터
@cocrystalpharma
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
COCP's Discussions on Twitter

COCP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
COCP 2.15 20.96M 0 -17.93M -14.28M -2.29
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-07-08 개시 H.C. Wainwright Buy

Cocrystal Pharma Inc 주식(COCP)의 최신 뉴스

pulisher
Nov 20, 2024

Cocrystal Pharma (STU:8CC) 14-Day RSI : 67.70 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Cocrystal Pharma (STU:8CC) GF Value Rank : 10 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 14, 2024

November 2024 US Exchange Standouts: Promising Penny Stocks - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Cocrystal Pharma (STU:8CC) 3-Year EPS without NRI Growth Ra - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Cocrystal Pharma Advances Clinical Trials Despite $4.9M Q3 Loss, Key Results Expected | COCP Stock News - StockTitan

Nov 13, 2024
pulisher
Oct 31, 2024

Cocrystal Pharma Advances Antiviral Drug Development - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

Cocrystal Pharma's Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - The Manila Times

Oct 31, 2024
pulisher
Oct 18, 2024

Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation - Yahoo Finance

Oct 18, 2024
pulisher
Oct 15, 2024

Pharmaceutical Grade Hydroxytyrosol Market Poised for Growth - openPR

Oct 15, 2024
pulisher
Oct 14, 2024

Influenza Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - openPR

Oct 14, 2024
pulisher
Oct 14, 2024

Seasonal Influenza Treatment Market Size, Treatment Drugs, and Companies 2024 - openPR

Oct 14, 2024
pulisher
Oct 11, 2024

Cocrystal Pharma execs get pay raise and stock grants By Investing.com - Investing.com Canada

Oct 11, 2024
pulisher
Oct 10, 2024

Cocrystal Pharma execs get pay raise and stock grants - Investing.com India

Oct 10, 2024
pulisher
Oct 10, 2024

Cocrystal Pharma Boosts Executive and Director Compensation - TipRanks

Oct 10, 2024
pulisher
Sep 27, 2024

Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma commences next phase of antiviral study - Investing.com

Sep 26, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma commences next phase of antiviral study By Investing.com - Investing.com Canada

Sep 26, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts - The Manila Times

Sep 26, 2024
pulisher
Sep 26, 2024

Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose - EIN News

Sep 26, 2024
pulisher
Sep 26, 2024

Seasonal Influenza Treatment Market Size in the 7MM was ~USD 9177 million in 2023, estimated DelveInsight - openPR

Sep 26, 2024
pulisher
Sep 25, 2024

Corover Secures $4 Mn In Series A Funding Led By Venture Catalysts - BW Disrupt

Sep 25, 2024
pulisher
Sep 24, 2024

K2 Principal Fund L.P. Takes $1.17 Million Position in CSLM Acquisition Corp. (NASDAQ:CSLM) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Coherent Corp (COHR) rating reiterates by Needham - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Corcel shares drop as explorer raise funds and ups exposure in Angola - Proactive Investors USA

Sep 24, 2024
pulisher
Sep 24, 2024

Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Corcel PLC Bolsters Angola Position with Increased Stake and Funding - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

Corcel (LON:CRCL) Trading 2.6% Higher - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Bearish block trade of CSPC PHARMA(01093) 768K shares at $4.94, $3.794M turnover - AASTOCKS.com

Sep 23, 2024
pulisher
Sep 21, 2024

CorVel Co. (NASDAQ:CRVL) Shares Acquired by Kayne Anderson Rudnick Investment Management LLC - MarketBeat

Sep 21, 2024
pulisher
Sep 20, 2024

Coherent (COHR) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance

Sep 20, 2024
pulisher
Sep 20, 2024

Momentum Is Driving Corning Stock Higher (NYSE:GLW) - Seeking Alpha

Sep 20, 2024
pulisher
Sep 20, 2024

Corbus stock reiterates Outperform rating despite trial data - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard

Sep 20, 2024
pulisher
Sep 19, 2024

Coherent Corp (COHR)’s Market Momentum: Closing Strong at 80.98, Up 3.93 - The Dwinnex

Sep 19, 2024
pulisher
Sep 19, 2024

Corning’s stock rises as it sticks to Q3 profit view - MarketWatch

Sep 19, 2024
pulisher
Sep 18, 2024

COHR’s Wild Ride: Up 82.75% – What’s Next for COHR? - The InvestChronicle

Sep 18, 2024
pulisher
Sep 18, 2024

Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors - Morningstar

Sep 18, 2024
pulisher
Sep 18, 2024

Commonwealth Equity Services LLC Has $996,000 Holdings in Compass Diversified (NYSE:CODI) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Examining the Potential Price Growth of CoreCivic Inc (CXW) - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Coherent (NYSE:COHR) delivers shareholders stellar 135% return over 1 year, surging 6.3% in the last week alone - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

Prepare Yourself for Liftoff: Coherent Corp (COHR) - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

Coherent Corp (COHR) receives a Buy rating from Needham - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Hollyland Cosmo C2 Wireless Video System First Look - Newsshooter

Sep 16, 2024
pulisher
Sep 16, 2024

State of New Jersey Common Pension Fund D Lowers Stock Holdings in Sea Limited (NYSE:SE) - Defense World

Sep 16, 2024
pulisher
Sep 16, 2024

LPL Financial LLC Has $46.81 Million Stake in iShares Fallen Angels USD Bond ETF (NASDAQ:FALN) - Defense World

Sep 16, 2024
pulisher
Sep 13, 2024

CoreCivic Inc [CXW] stock for 106,240 USD was sold by Carter, Cole G. - Knox Daily

Sep 13, 2024

Cocrystal Pharma Inc (COCP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
자본화:     |  볼륨(24시간):